283 related articles for article (PubMed ID: 17137541)
1. The preteen visit: an opportunity for prevention.
Campos-Outcalt D
J Fam Pract; 2006 Dec; 55(12):1054-6. PubMed ID: 17137541
[TBL] [Abstract][Full Text] [Related]
2. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine and/or meningococcal conjugate vaccine to healthy girls 11 to 18 years of age: results from a randomized open trial.
Wheeler CM; Harvey BM; Pichichero ME; Simon MW; Combs SP; Blatter MM; Marshall GS; Catteau G; Dobbelaere K; Descamps D; Dubin G; Schuind A
Pediatr Infect Dis J; 2011 Dec; 30(12):e225-34. PubMed ID: 21817954
[TBL] [Abstract][Full Text] [Related]
4. Vaccination coverage among adolescents aged 13-17 years - United States, 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(40):1100-3. PubMed ID: 18846032
[TBL] [Abstract][Full Text] [Related]
5. Immunizations. New recommendations for children's vaccines: one against meningitis..Tdap [corrected] "booster" for 11-12 year olds...but not a booster for chicken pox.
Child Health Alert; 2005 Sep; 24():2-3. PubMed ID: 16237805
[No Abstract] [Full Text] [Related]
6. Adolescent Vaccination Performance in South Carolina Compared to the United States.
Roberts JR; Naifeh M; Jacobson RM; Hinton E; O'Brien E; Rogacki B; Thompson D; Margolis B; Darden PM
J S C Med Assoc; 2015 Dec-2016 Jan; 111(4):117-21. PubMed ID: 27141702
[TBL] [Abstract][Full Text] [Related]
7. Middle school vaccination requirements and adolescent vaccination coverage.
Bugenske E; Stokley S; Kennedy A; Dorell C
Pediatrics; 2012 Jun; 129(6):1056-63. PubMed ID: 22566425
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and cost of immunization recall at school-based health centers.
Kempe A; Barrow J; Stokley S; Saville A; Glazner JE; Suh C; Federico S; Abrams L; Seewald L; Beaty B; Daley MF; Dickinson LM
Pediatrics; 2012 Jun; 129(6):e1446-52. PubMed ID: 22566414
[TBL] [Abstract][Full Text] [Related]
9. Syncope after vaccination--United States, January 2005-July 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 May; 57(17):457-60. PubMed ID: 18451756
[TBL] [Abstract][Full Text] [Related]
10. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.
Pichichero ME; Blatter MM; Kennedy WA; Hedrick J; Descamps D; Friedland LR
Pediatrics; 2006 Apr; 117(4):1084-93. PubMed ID: 16585302
[TBL] [Abstract][Full Text] [Related]
11. Adolescent vaccine co-administration and coverage in New York City: 2007-2013.
Sull M; Eavey J; Papadouka V; Mandell R; Hansen MA; Zucker JR
Pediatrics; 2014 Dec; 134(6):e1576-83. PubMed ID: 25384490
[TBL] [Abstract][Full Text] [Related]
12. A population-level assessment of factors associated with uptake of adolescent-targeted vaccines in Michigan.
Gowda C; Dong S; Potter RC; Dombkowski KJ; Dempsey AF
J Adolesc Health; 2013 Oct; 53(4):498-505. PubMed ID: 24054080
[TBL] [Abstract][Full Text] [Related]
13. New adolescent vaccination recommendations and how to make them "stick".
Middleman AB
Curr Opin Pediatr; 2007 Aug; 19(4):411-6. PubMed ID: 17630604
[TBL] [Abstract][Full Text] [Related]
14. Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study.
Jackson LA; Yu O; Nelson J; Belongia EA; Hambidge SJ; Baxter R; Naleway A; Nordin J; Baggs J; Iskander J
Vaccine; 2009 Aug; 27(36):4912-6. PubMed ID: 19567245
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines.
Arguedas A; Soley C; Loaiza C; Rincon G; Guevara S; Perez A; Porras W; Alvarado O; Aguilar L; Abdelnour A; Grunwald U; Bedell L; Anemona A; Dull PM
Vaccine; 2010 Apr; 28(18):3171-9. PubMed ID: 20189491
[TBL] [Abstract][Full Text] [Related]
16. National, state, and local area vaccination coverage among adolescents aged 13-17 years--United States, 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(36):997-1001. PubMed ID: 19763075
[TBL] [Abstract][Full Text] [Related]
17. Update on immunizations in children and adolescents.
Ackerman LK
Am Fam Physician; 2008 Jun; 77(11):1561-8. PubMed ID: 18581836
[TBL] [Abstract][Full Text] [Related]
18. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(34):671-7. PubMed ID: 22932301
[TBL] [Abstract][Full Text] [Related]
19. Notes from the field : use of tetanus, diphtheria, and pertussis vaccine (Tdap) in an Emergency Department - Arizona, 2009-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Jan; 61(3):55-6. PubMed ID: 22278160
[TBL] [Abstract][Full Text] [Related]
20. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA;
Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
